Advertisement
Screener

SI-BONE, INC. (SIBN) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

SI-BONE, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

SI-BONE, INC. (SIBN) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $17.31 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-01.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2022-03-01

  • SI-BONE, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2020-03-31 was $17.31, a 21.32% decline year-over-year.
  • SI-BONE, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2019-03-31 was $22.00.
  • SI-BONE, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2018-09-30 was $9.88.
  • SI-BONE, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2020 was $17.31, a 17.14% decline from fiscal 2019.
  • SI-BONE, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2019 was $20.89, a 135.25% increase from fiscal 2018.
  • SI-BONE, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2018 was $8.88.
Period endShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month
2020-12-31$17.31
10-K · filed 2022-03-01
2020-09-30$17.31
10-Q · filed 2020-11-03
2020-06-30$17.31
10-Q · filed 2020-08-04
2020-03-31$17.31
10-Q · filed 2020-05-05
2019-12-31$20.89
10-K · filed 2021-03-10
2019-09-30$20.89
10-Q · filed 2019-11-12
2019-06-30$20.91
10-Q · filed 2019-08-07
2019-03-31$22.00
10-Q · filed 2019-05-09
2018-12-31$8.88
10-K · filed 2020-03-11
2018-09-30$9.88
10-Q · filed 2018-11-29
$5.51
10-Q · filed 2018-11-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
SpyGlass Pharma, Inc. (SGP)United States$0.925B
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
SS Innovations International, Inc. (SSII)$0.589B-64.06
IRADIMED CORP (IRMD)United States$1.089B52.92
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33